Literature DB >> 23872499

Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.

Chander Shekhar1, Phillip J Monaghan, Julie Morris, Basma Issa, Peter J Whorwell, Brian Keevil, Lesley A Houghton.   

Abstract

BACKGROUND & AIMS: Patients with irritable bowel syndrome with constipation (IBS-C) and patients with functional constipation (FC) have similar symptoms, and these disorders overlap in their diagnostic features. Little is known about their overlap in physiology or the involvement of serotonin signaling. We investigated relationships between platelet-depleted plasma concentrations of serotonin, gastrointestinal symptoms, and motor-sensory function in patients with FC or IBS-C compared with healthy volunteers (controls).
METHODS: We measured platelet-depleted plasma concentrations of serotonin in fasting and fed individuals with IBS-C (n = 23; 19-50 years old), FC (n = 11; 25-46 years old), and controls (n = 23; 20-49 years old) recruited in Manchester, UK. We also quantified abdominal and bowel-related symptoms, rectal sensitivity, oro-cecal transit, and colonic (whole intestine) transit.
RESULTS: Patients with IBS-C or FC had similar baseline symptoms, bowel habits, oro-cecal and colonic transit, and fasting concentrations of serotonin and response to meal ingestion. Only patients with IBS-C had increased symptoms after ingestion of a meal (P < .001)-these patients tended to have lower sensory thresholds than patients with FC. Defecation frequency in the combined group of patients with IBS-C or FC correlated inversely with serotonin concentration (r = -0.4; P = .03). Serotonin concentration also correlated with pain threshold (r = 0.4; P = .02) and stool threshold (r = 0.5; P = .06), which correlated inversely with defecation frequency (r = -0.3; P = .10).
CONCLUSIONS: FC and IBS-C, based on Rome III criteria, are not distinct disorders, symptomatically or physiologically. Instead, they appear to lie in a spectrum of visceral sensitivity modulated by serotonin signaling. Symptom response to meal ingestion should be considered in patient classification.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-HT; 5-Hydroxytryptamine; 5-hydroxytryptamine; EC; FC; HV; IBS-C; IBS-D; Neurotransmitter; PDP; SSRI; Visceral Sensitivity; enterochromaffin; functional constipation; healthy volunteer; irritable bowel syndrome with constipation; irritable bowel syndrome with diarrhea; platelet-depleted plasma; selective serotonin reuptake inhibitor

Mesh:

Substances:

Year:  2013        PMID: 23872499     DOI: 10.1053/j.gastro.2013.07.014

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  42 in total

1.  Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis.

Authors:  K Staller; K Barshop; B Kuo; A N Ananthakrishnan
Journal:  Neurogastroenterol Motil       Date:  2015-07-14       Impact factor: 3.598

Review 2.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

3.  Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea.

Authors:  Prashant Singh; Ha-Neul Lee; Vikram Rangan; Sarah Ballou; Joseph Lembo; Jesse Katon; Courtney McMahon; Daniel Friedlander; Johanna Iturrino; Judy Nee; Anthony Lembo
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-20       Impact factor: 11.382

4.  Rectal Gas Volume Measured by Computerized Tomography Identifies Evacuation Disorders in Patients With Constipation.

Authors:  Seon-Young Park; Disha Khemani; Alfred D Nelson; Deborah Eckert; Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-14       Impact factor: 11.382

5.  Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation.

Authors:  Gopanandan Parthasarathy; Jun Chen; Xianfeng Chen; Nicholas Chia; Helen M O'Connor; Patricia G Wolf; H Rex Gaskins; Adil E Bharucha
Journal:  Gastroenterology       Date:  2015-10-13       Impact factor: 22.682

6.  Chronic Constipation and Constipation-Predominant IBS: Separate and Distinct Disorders or a Spectrum of Disease?

Authors:  Kewin T H Siah; Reuben K Wong; William E Whitehead
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-03

7.  Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Jin Young Yoon; Jae Myung Cha; Ju Kyoung Oh; Pei Lei Tan; Sae Hun Kim; Min Seob Kwak; Jung Won Jeon; Hyun Phil Shin
Journal:  Dig Dis Sci       Date:  2018-06-07       Impact factor: 3.199

Review 8.  Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments.

Authors:  Full-Young Chang
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

9.  Irritable bowel syndrome is associated not only with organic but also psychogenic erectile dysfunction.

Authors:  C-Y Hsu; C-L Lin; C-H Kao
Journal:  Int J Impot Res       Date:  2015-10-08       Impact factor: 2.896

Review 10.  Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms.

Authors:  Michael Camilleri
Journal:  J Physiol       Date:  2014-03-24       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.